Therapeutic Uses
Anti-Asthma / COPD
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
3-((Cyclopropyl-2,2,3,3-D4)methoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Roflumilast-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Roflumilast-d4 usage and description
Roflumilast D4 is a deuterated version of the drug Roflumilast, which is a phosphodiesterase 4 (PDE4) inhibitor. This medication is used to treat chronic obstructive pulmonary disease (COPD) in patients with a history of severe exacerbations. COPD is a progressive lung disease characterized by inflammation and narrowing of the airways, leading to breathing difficulties and reduced lung function.
Roflumilast D4 works by reducing inflammation in the lungs, which helps to improve breathing and reduce the risk of exacerbations. It is believed to do this by inhibiting the activity of PDE4, an enzyme that is involved in the production of inflammatory molecules in the body.
Chemically, Roflumilast D4 is a deuterated version of Roflumilast, meaning that it contains deuterium atoms in place of some of the hydrogen atoms in the molecule. Deuterium is a stable isotope of hydrogen that has a slightly greater mass, which can affect the way that the drug is metabolized in the body. This modification can increase the half-life of the drug, which may improve its effectiveness and reduce the frequency of dosing required.
In summary, Roflumilast D4 is a medication used to treat COPD by reducing inflammation in the lungs. It is a deuterated version of Roflumilast, which may improve its pharmacokinetic properties.
